1. Injecting and BBVs – NDTMS and prevalence data Current prevalence data for injecting among opiate/crack users (2010/11) shows continuation of a steady decline in the number of injectors 1Injecting and BBVs – NDTMS and prevalence data

2. This is reflected in a decrease in the number and proportion of current injectors entering treatment – in 2011/12 this was 18% (~12,000) 2Injecting and BBVs – NDTMS and prevalence data

3. NDTMS does not contain data on whether an individual has hepatitis B or hepatitis C, but rather whether they have been offered and received the appropriate vaccination or testing Performance of providers against these indicators is monitored through routine reporting (e.g. DOMES) Also submit data for use in regular Health Protection projects (Hep C estimates; Hepatitis C in the UK Report) 3Injecting and BBVs – NDTMS and prevalence data

4. Uptake and receipt of hepatitis B vaccinations has declined slightly over the last three years 4Injecting and BBVs – NDTMS and prevalence data

5. Rates of acceptance and receipt of hepatitis C tests among those with an injecting history have continued to increase over the last three years, although has levelled off in the past year 5Injecting and BBVs – NDTMS and prevalence data